QuadraMed Corporation Common Stock Moving to NASDAQ

  
    
  
  
    
      QuadraMed® 
      Corporation (AMEX:QD) today announces that it has received approval 
      to list its common stock, par value $0.01, on the NASDAQ Global Market 
      under the symbol QDHC. The Company has informed the American Stock 
      Exchange (AMEX) of its intention to list on the NASDAQ Global Market and 
      to delist its common stock from the AMEX. The Company believes 
      that listing the Company’s common stock 
      on the NASDAQ Global Market and delisting the Company’s 
      common stock from the AMEX will increase investor and analyst attention 
      and provide the Company’s investors with a 
      better environment for trading shares of the Company’s 
      common and preferred stock (which are convertible into shares of common 
      stock).
    
    
      On July 8, 2008, QuadraMed plans to file with the Securities and 
      Exchange Commission an application on Form 25 to strike its common stock 
      from listing on the AMEX and a Form 8-A in conjunction with the listing 
      of its common stock on the NASDAQ Global Market. QuadraMed anticipates 
      that as of Wednesday, July 9, 2008 its common stock will trade on the 
      NASDAQ Global Market under a new trading symbol, QDHC, and will no 
      longer trade on the AMEX.
    
    
      "We believe that QuadraMed’s transition 
      to the world’s foremost technology stock 
      market will increase the effective marketability of our common stock to 
      institutional investors and heighten Wall Street’s 
      interest in our company,” said Keith Hagen, 
      QuadraMed’s president and CEO. “After 
      much analysis, we believe that listing our stock on the fully electronic 
      exchange of NASDAQ will generate higher visibility and trading volume, 
      in alignment with the best interests of our company and shareholders.”
    
    
      About QuadraMed Corporation
    
    
      QuadraMed Corporation advances the success of healthcare organizations 
      through IT solutions that leverage quality care into positive financial 
      outcomes. QuadraMed provides real world solutions that help healthcare 
      professionals deliver outstanding patient care efficiently and cost 
      effectively. Behind the company’s products 
      and services is a staff of 650 professionals whose experience and 
      dedication have earned QuadraMed the trust and loyalty of clients at 
      over 2,000 healthcare provider facilities. For more information about 
      QuadraMed, visit http://www.quadramed.com.
    
    
      About NASDAQ
    
    
      NASDAQ® is the largest U.S. electronic stock 
      market. With approximately 3,200 companies, it lists more companies and, 
      on average, its systems trade more shares per day than any other U.S. 
      market. NASDAQ is home to companies that are leaders across all areas of 
      business including technology, retail, communications, financial 
      services, transportation, media and biotechnology. NASDAQ is the primary 
      market for trading NASDAQ-listed stocks. For more information about 
      NASDAQ, visit the NASDAQ website at http://www.nasdaq.com 
      or the NASDAQ Newsroom(SM) at http://www.nasdaq.com/newsroom.
    
    
      Cautionary Statement on Risks Associated with QuadraMed 
      Forward-Looking Statements
    
    
      This press release contains forward-looking statements within the 
      meaning of the Private Securities Litigation Reform Act of 1995 by 
      QuadraMed that are subject to risks and uncertainties. The words 
      "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," 
      "should," "could," and similar expressions are intended to identify such 
      statements. Forward-looking statements are not guarantees of future 
      performance and are to be interpreted only as of the date on which they 
      are made. QuadraMed undertakes no obligation to update or revise any 
      forward-looking statement except as required by law. QuadraMed advises 
      investors that it discusses risk factors and uncertainties that could 
      cause QuadraMed’s actual results to differ 
      from forward-looking statements in its periodic reports filed with the 
      Securities and Exchange Commission ("SEC"). QuadraMed’s 
      SEC filings can be accessed through the Investor Relations section of 
      our website, www.quadramed.com, 
      or through the SEC’s EDGAR Database at www.sec.gov 
      (QuadraMed has EDGAR CIK No. 0001018833).
    
    
      QuadraMed is a registered trademark of QuadraMed Corporation. All other 
      trademarks are the property of their respective holders.